Navigation Links
Dynatronics Receives 180-Day NASDAQ Extension
Date:12/10/2009

SALT LAKE CITY, Dec. 10 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced that following last month's panel hearing, NASDAQ granted Dynatronics a full 180-day extension for regaining compliance with the $1.00 minimum bid requirement.

"We are pleased the panel granted us the full 180-day extension we requested," stated Kelvyn H. Cullimore Jr., chairman and president of Dynatronics. "This will allow time for the market to consider important positive announcements we have recently made as well as additional positive announcements expected during the extension period. We believe the good financial results from our year ended June 30, 2009 combined with the trend of five consecutive profitable quarters provide important momentum going into this extension period. We will also have the opportunity during the extension period to report our financial results for the quarter ending December 31, 2009. We trust these factors will all help us move toward regaining compliance with the NASDAQ requirement."

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at http://www.dynatronics.com.

This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements such as the statement regarding the opportunity to make future announcements and move toward regaining compliance with NASDAQ's minimum bid requirement. Actual results may vary from the vie
'/>"/>

SOURCE Dynatronics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
2. Dynatronics Will Request Hearing With Nasdaq Regarding Listing Status
3. Dynatronics to Release First Quarter Results Friday, November 13, 2009; Conference Call Set for 1:30 p.m. ET
4. Dynatronics Announces Positive Financial Results for Quarter
5. Dynatronics Named Sole-Source Supplier to Benchmark Physical Therapy
6. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
7. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
9. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
10. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
11. CryoCor Receives FDA Approval for Right Atrial Flutter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013  In a letter to ... , M.D., of Lake View, Iowa , ... receive annual influenza vaccine is neither scientifically justified nor ethically ... article in the summer issue of the Journal ... official statistics are correct, and an average of 36,000 patients ...
(Date:6/18/2013)... Decision Resources, one of the world,s leading research and advisory ... past 12 months, 25 percent of surveyed physicians from the ... , Italy , Spain ... been required to change the antiretroviral (ARV) prescription for some ... Additionally, more than 40 percent of respondents report that changing ...
(Date:6/18/2013)... June 18, 2013 New-generation electronic designs ... portable and lightweight. Simultaneously, circuitry is increasing the ... speed to which it performs at. Connecting cables ... and military equipment, such as cameras or detectors, ... and nano-circular connectors include custom cable designs for ...
Breaking Medicine Technology:Mandated Flu Vaccine for Hospital Workers Ethically Questionable, Surgeon Writes 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2
... , ABBOTT PARK, Ill., Nov. 12 Nearly one in ... normal and nearly 34 million have low HDL "good" cholesterol ... HDL and trigs, Abbott has launched two Web sites: ... , "Unhealthy high triglyceride and low HDL levels are factors ...
... a leader in fluorescence in vivo imaging from ... new Cat B 750 FAST(TM) imaging agent for ... and therapeutic response in vivo . Cathepsin B ... target in a range of diseases, including atherosclerosis, oncology, and ...
Cached Medicine Technology:New Web Sites Educate About Triglycerides and HDL Cholesterol 2VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting 2VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting 3
(Date:6/18/2013)... have discovered and mapped the signaling network between two ... could cut off cancer cell growth at its starting ... University of Texas MD Anderson Cancer Center reported the ... cancer drug target, and MCM7, a protein vital to ... issue of Cancer Cell . , "MCM7 overexpression ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The July 2013 ... Cheater’s Guide to Getting Beach Ready,” offers a list of ... look their best in a bathing suit this summer. The ... skin firming , smoothing cellulite , and more. (go ... Ourian, Medical Director of Epione Beverly Hills, “though I would ...
(Date:6/18/2013)... June 18, 2013 myCNAjobs announces the ... free downloads, articles, and tips to the Caregiver Resources ... care for the 10,000+ retiring baby boomers each day, ... caregiver job resources has never been greater. ... job community, recently launched the first-ever free resource ...
(Date:6/18/2013)... June 18, 2013 Healthcare ... ScripNet and Procura Management, today announced the appointment ... sales officer. In this position, Leonardo will direct ... the company’s strategic growth initiatives. , Recognized in ... and expertise, Leonardo brings more than 20 years ...
(Date:6/18/2013)... June 18, 2013 Today, Zane Benefits, ... Reimbursement Accounts . Zane Benefits, which provides comprehensive and ... the leader in defined contribution and ... Benefits’ website, employees of a company who sets up ... questions about how Health Reimbursement Accounts work. Educating employees ...
Breaking Medicine News(10 mins):Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:Skin Care – Getting Your Body Beach Ready 2Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Zane Benefits Publishes New Information on Health Reimbursement Accounts 2
... 8 Pieris AG,a biopharmaceutical company developing Anticalins(R), ... announced the appointment of Dr,Angelika Stern as Chief ... the promotion with immediate effect of Dr Andreas ... Preclinical Development to Chief,Technology Officer. The appointment ...
... November 8 - Healthcare Businesswomen,s ... Groundbreaking Study and Best Practices for,Recruitment, Retention, ... the highly anticipated Healthcare Businesswomen,s,Association (HBA) E.D.G.E. ... exceeded the expectations of pharmaceutical senior,management, who ...
... Cell Therapeutics, Inc. (CTI),(Nasdaq and MTAX: CTIC) today reported recent ... September 30, 2007. Recent Events, -- Announced agreement ... first FDA-approved radioimmunotherapy, from Biogen Idec; this ... group of only a few biotech ...
... - Revenue for the third quarter was $464.6 million, Facility Operating ... - Average occupancy for the quarter was 90.8%, and average revenue per, ... ... quarter.,- Cash From Facility Operations for the quarter was $43.3 million, or $0.43, ...
... Leader Joins Healthcare ... Management Consulting Practice, SANTA ANA, Calif., ... appointment of Ogan Gurel, M.D. as a Managing,Director with its ... join our team," said Vip Jain - Principal and,Head of ...
... Inc. (OTC,Bulletin Board: GOVX), an Atlanta based biotechnology ... Ph.D. has been elected,"Fellow of the American Association ... "Fellow" is an honor bestowed upon AAAS members ... science or its,applications. Emory University professor and Asa ...
Cached Medicine News:Health News:Pieris Strengthens its Management, as it Prepares for the Clinical Development of PRS-050, an Anticalin(R)-Based Novel Cancer Therapy 2Health News:Pieris Strengthens its Management, as it Prepares for the Clinical Development of PRS-050, an Anticalin(R)-Based Novel Cancer Therapy 3Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 2Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 3Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 4Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 5Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results 2Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results 3Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results 4Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results 5Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results 6Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results 7Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results 8Health News:Brookdale Announces Third Quarter 2007 Results 2Health News:Brookdale Announces Third Quarter 2007 Results 3Health News:Brookdale Announces Third Quarter 2007 Results 4Health News:Brookdale Announces Third Quarter 2007 Results 5Health News:Brookdale Announces Third Quarter 2007 Results 6Health News:Brookdale Announces Third Quarter 2007 Results 7Health News:Brookdale Announces Third Quarter 2007 Results 8Health News:Brookdale Announces Third Quarter 2007 Results 9Health News:Brookdale Announces Third Quarter 2007 Results 10Health News:Brookdale Announces Third Quarter 2007 Results 11Health News:Brookdale Announces Third Quarter 2007 Results 12Health News:Brookdale Announces Third Quarter 2007 Results 13Health News:Brookdale Announces Third Quarter 2007 Results 14Health News:Brookdale Announces Third Quarter 2007 Results 15Health News:Brookdale Announces Third Quarter 2007 Results 16Health News:Brookdale Announces Third Quarter 2007 Results 17Health News:Brookdale Announces Third Quarter 2007 Results 18Health News:Brookdale Announces Third Quarter 2007 Results 19Health News:Brookdale Announces Third Quarter 2007 Results 20Health News:Brookdale Announces Third Quarter 2007 Results 21Health News:XRoads Solutions Group Appoints Dr. Ogan Gurel as Managing Director 2Health News:GeoVax Co-Founder Dr. Harriet Robinson Named 2007 AAAS Fellow 2
Bi-Directional doppler volume flowmeter....
... frequency and multigate transcranial ... and fitted with a ... for hemodynamic evaluation. Looki ... well for routine diagnosis ...
One channel, one gate transcranial Doppler that is diagnosis oriented with an advanced protocol editor, automatic report generator and a powerful examination data base....
One channel transcranial Doppler...
Medicine Products: